Paragraph IV Challenges

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Tradename	Dosage	Generic Name	NDA	Submissiondate
BELVIQ	TABLET;ORAL	lorcaserin hydrochloride	022529	2020-06-27
TRIJARDY XR	TABLET, EXTENDED RELEASE;ORAL	empagliflozin; linagliptin; metformin hydrochloride	212614	2020-05-26
BRIVIACT	SOLUTION;ORAL	brivaracetam	205838	2020-05-12
BRIVIACT	SOLUTION;INTRAVENOUS	brivaracetam	205837	2020-05-12
PROCYSBI	CAPSULE, DELAYED RELEASE;ORAL	cysteamine bitartrate	203389	2020-05-11
GOCOVRI	CAPSULE, EXTENDED RELEASE;ORAL	amantadine hydrochloride	208944	2020-04-30
NUPLAZID	TABLET;ORAL	pimavanserin tartrate	207318	2020-04-29
>Tradename	>Dosage	>Generic Name	>NDA	>Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.